Treatment Patterns and Overall Survival Outcomes of Octogenarians with Muscle Invasive Cancer of the Bladder: An Analysis of the National Cancer Database-Reference-Cited by-同舟云学术

Treatment Patterns and Overall Survival Outcomes of Octogenarians with Muscle Invasive Cancer of the Bladder: An Analysis of the National Cancer Database

Published:2018-02 Issue:2 Volume:199 Page:416-423
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Fischer-Valuck Benjamin W.¹,Rao Yuan James¹,Rudra Soumon¹,Przybysz Daniel¹,Germino Elizabeth¹,Samson Pamela¹,Baumann Brian C.¹,Gay Hiram¹,Michalski Jeff¹

Affiliation:

1. Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference18 articles.

1. Global burden of urologic cancers, 1990-2013;Dy;Eur Urol,2017

2. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

3. Neoadjuvant chemotherapy in elderly patients with bladder cancer: oncologic outcomes from a single institution experience;Leone;Clin Genitourin Cancer,2017

4. Muscle-invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base;Smith;BJU Int,2014

5. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer;Grossman;N Engl J Med,2003

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural history and health care burden of non-curative treatment for muscle-invasive bladder cancer;Urologic Oncology: Seminars and Original Investigations;2024-08

2. Assessing the safety of bladder-preserving therapy as an alternative to surgical intervention in elderly patients with muscle invasive bladder cancer;Urologia Journal;2024-07-26

3. Age related trends in the utilization of neoadjuvant chemotherapy for muscle invasive bladder cancer;Urologic Oncology: Seminars and Original Investigations;2024-05

4. Predictors of response to neoadjuvant therapy in urothelial cancer;Critical Reviews in Oncology/Hematology;2024-02

5. Safety, Tolerability, and Preliminary Efficacy of TAR-200 in Patients With Muscle-invasive Bladder Cancer Who Refused or Were Unfit for Curative-intent Therapy: A Phase 1 Study;Journal of Urology;2023-05